269 related articles for article (PubMed ID: 34608194)
21. A small-molecule screen identifies the antipsychotic drug pimozide as an inhibitor of Listeria monocytogenes infection.
Lieberman LA; Higgins DE
Antimicrob Agents Chemother; 2009 Feb; 53(2):756-64. PubMed ID: 19015342
[TBL] [Abstract][Full Text] [Related]
22. Drug Discovery Platform Targeting M. tuberculosis with Human Embryonic Stem Cell-Derived Macrophages.
Han HW; Seo HH; Jo HY; Han HJ; Falcão VCA; Delorme V; Heo J; Shum D; Choi JH; Lee JM; Lee SH; Heo HR; Hong SH; Park MH; Thimmulappa RK; Kim JH
Stem Cell Reports; 2019 Dec; 13(6):980-991. PubMed ID: 31680058
[TBL] [Abstract][Full Text] [Related]
23. The SecA2 pathway of Mycobacterium tuberculosis exports effectors that work in concert to arrest phagosome and autophagosome maturation.
Zulauf KE; Sullivan JT; Braunstein M
PLoS Pathog; 2018 Apr; 14(4):e1007011. PubMed ID: 29709019
[TBL] [Abstract][Full Text] [Related]
24. A multidrug efflux protein in Mycobacterium tuberculosis; tap as a potential drug target for drug repurposing.
Dwivedi M; Mukhopadhyay S; Yadav S; Dubey KD
Comput Biol Med; 2022 Jul; 146():105607. PubMed ID: 35617724
[TBL] [Abstract][Full Text] [Related]
25. Cationic amphipathic D-enantiomeric antimicrobial peptides with in vitro and ex vivo activity against drug-resistant Mycobacterium tuberculosis.
Lan Y; Lam JT; Siu GK; Yam WC; Mason AJ; Lam JK
Tuberculosis (Edinb); 2014 Dec; 94(6):678-89. PubMed ID: 25154927
[TBL] [Abstract][Full Text] [Related]
26. The evaluation of the anti-cancer drug elesclomol that forms a redox-active copper chelate as a potential anti-tubercular drug.
Ngwane AH; Petersen RD; Baker B; Wiid I; Wong HN; Haynes RK
IUBMB Life; 2019 May; 71(5):532-538. PubMed ID: 30698324
[TBL] [Abstract][Full Text] [Related]
27. Autophagy induction targeting mTORC1 enhances Mycobacterium tuberculosis replication in HIV co-infected human macrophages.
Andersson AM; Andersson B; Lorell C; Raffetseder J; Larsson M; Blomgran R
Sci Rep; 2016 Jun; 6():28171. PubMed ID: 27302320
[TBL] [Abstract][Full Text] [Related]
28. Mycobacterium tuberculosis High-Throughput Screening.
White EL; Tower NA; Rasmussen L
Methods Mol Biol; 2016; 1439():181-95. PubMed ID: 27316996
[TBL] [Abstract][Full Text] [Related]
29. Bis-biguanide dihydrochloride inhibits intracellular replication of M. tuberculosis and controls infection in mice.
Shen H; Wang F; Zeng G; Shen L; Cheng H; Huang D; Wang R; Rong L; Chen ZW
Sci Rep; 2016 Sep; 6():32725. PubMed ID: 27601302
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of Transglutaminase 2 as a Potential Host-Directed Therapy Against
Palucci I; Maulucci G; De Maio F; Sali M; Romagnoli A; Petrone L; Fimia GM; Sanguinetti M; Goletti D; De Spirito M; Piacentini M; Delogu G
Front Immunol; 2019; 10():3042. PubMed ID: 32038614
[TBL] [Abstract][Full Text] [Related]
31. Bazedoxifene Suppresses Intracellular Mycobacterium tuberculosis Growth by Enhancing Autophagy.
Ouyang Q; Zhang K; Lin D; Feng CG; Cai Y; Chen X
mSphere; 2020 Apr; 5(2):. PubMed ID: 32269154
[TBL] [Abstract][Full Text] [Related]
32. FDA-Approved Amoxapine Effectively Promotes Macrophage Control of Mycobacteria by Inducing Autophagy.
Wang J; Sha J; Strong E; Chopra AK; Lee S
Microbiol Spectr; 2022 Oct; 10(5):e0250922. PubMed ID: 36129262
[TBL] [Abstract][Full Text] [Related]
33. Ursolic Acid Promotes Autophagy by Inhibiting Akt/mTOR and TNF-α/TNFR1 Signaling Pathways to Alleviate Pyroptosis and Necroptosis in Mycobacterium tuberculosis-Infected Macrophages.
Shen J; Fu Y; Liu F; Ning B; Jiang X
Inflammation; 2023 Oct; 46(5):1749-1763. PubMed ID: 37212951
[TBL] [Abstract][Full Text] [Related]
34. The Lipid Virulence Factors of
Bah A; Sanicas M; Nigou J; Guilhot C; Astarie-Dequeker C; Vergne I
Cells; 2020 Mar; 9(3):. PubMed ID: 32182946
[TBL] [Abstract][Full Text] [Related]
35. A New Screen for Tuberculosis Drug Candidates Utilizing a Luciferase-Expressing Recombinant Mycobacterium bovis Bacillus Calmette-Guéren.
Ozeki Y; Igarashi M; Doe M; Tamaru A; Kinoshita N; Ogura Y; Iwamoto T; Sawa R; Umekita M; Enany S; Nishiuchi Y; Osada-Oka M; Hayashi T; Niki M; Tateishi Y; Hatano M; Matsumoto S
PLoS One; 2015; 10(11):e0141658. PubMed ID: 26571296
[TBL] [Abstract][Full Text] [Related]
36. Loxapine, an antipsychotic drug, suppresses intracellular multiple-antibiotic-resistant Salmonella enterica serovar Typhimurium in macrophages.
Yang CY; Hsu CY; Fang CS; Shiau CW; Chen CS; Chiu HC
J Microbiol Immunol Infect; 2019 Aug; 52(4):638-647. PubMed ID: 31239204
[TBL] [Abstract][Full Text] [Related]
37. Repurposing Saquinavir for Host-Directed Therapy to Control Mycobacterium Tuberculosis Infection.
Pires D; Valente S; Calado M; Mandal M; Azevedo-Pereira JM; Anes E
Front Immunol; 2021; 12():647728. PubMed ID: 33841429
[TBL] [Abstract][Full Text] [Related]
38. From infection niche to therapeutic target: the intracellular lifestyle of
Rankine-Wilson LI; Shapira T; Sao Emani C; Av-Gay Y
Microbiology (Reading); 2021 Apr; 167(4):. PubMed ID: 33826491
[No Abstract] [Full Text] [Related]
39. Host-directed therapy targeting the Mycobacterium tuberculosis granuloma: a review.
Kiran D; Podell BK; Chambers M; Basaraba RJ
Semin Immunopathol; 2016 Mar; 38(2):167-83. PubMed ID: 26510950
[TBL] [Abstract][Full Text] [Related]
40. Functional drug screening reveals anticonvulsants as enhancers of mTOR-independent autophagic killing of Mycobacterium tuberculosis through inositol depletion.
Schiebler M; Brown K; Hegyi K; Newton SM; Renna M; Hepburn L; Klapholz C; Coulter S; Obregón-Henao A; Henao Tamayo M; Basaraba R; Kampmann B; Henry KM; Burgon J; Renshaw SA; Fleming A; Kay RR; Anderson KE; Hawkins PT; Ordway DJ; Rubinsztein DC; Floto RA
EMBO Mol Med; 2015 Feb; 7(2):127-39. PubMed ID: 25535254
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
